[7/23/2020] To reduce the risk of death from opioid overdose, the U.S. Food and Drug Administration has made the following recommendations about the opioid reversal medicine, […]

Benzodiazepines are a class of medicines approved to treat generalized anxiety disorder, insomnia, seizures, social phobia, and panic disorder. Benzodiazepines are also used as premedication before […]

TOPIC: Benzodiazepine Drug Class: Drug Safety Communication – Boxed Warning Updated to Improve Safe Use AUDIENCE: Patient, Health Professional, Pharmacy ISSUE: The FDA is requiring the […]

Sedative-hypnotic drug products are a class of drugs used to induce and/or maintain sleep. FDA Drug Safety Communications: Prescription Insomnia Drugs (UPDATED) For prescribing information, please […]

The FDA has issued new information about this safety issue, see the FDA Drug Safety Communication issued on 12-12-2016. [8-4-2011] The U.S. Food and Drug Administration […]

[ 4-27-2017 ] The U.S. Food and Drug Administration (FDA) is notifying the public that we have approved previously announced label changes regarding the use of […]